Nambu R, Iwama I, Takeuchi I, Hagiwara SI, et al. Real-world outcomes of ustekinumab, vedolizumab, and tumor necrosis factor inhibitors in very-early-onset inflammatory bowel disease: a multi-center cohort study. J Gastroenterol 2026 Jan 3. doi: 10.1007/s00535-025-02334.
PMID: 41483143